1. The COVID-19 vaccine supply is outweighing demand in more than 1,000 U.S. counties, according to pharmacy discount company GoodRx.. 2. Novax may get its COVID-19 vaccine approved next.Here are ...

According to phase 3 trial results Novavax released in February, overall vaccine efficacy in a cohort of more than 2,200 adolescents was 79.5% against PCR-positive mild, moderate or severe COVID ...